%0 Journal Article
%A Funk, Maximilian A
%A Theurich, Sebastian
%T Targeting BCMA in CIDP: Valuable insights gained through multi-omics immune monitoring.
%J Med
%V 6
%N 9
%@ 2666-6340
%C Amsterdam
%I Elsevier
%M DKFZ-2025-01909
%P 100753
%D 2025
%X Dong et al. present two patients with refractory chronic inflammatory demyelinating polyneuropathy (CIDP), who received treatment with B-cell-maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR)-T cells.1 Extensive concomitant immune monitoring provides insights into the pathogenesis and mechanisms of relapse in CIDP that may help to determine the role of BCMA-targeted CAR-T cell therapy for this disease in the future.
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:40945500
%R 10.1016/j.medj.2025.100753
%U https://inrepo02.dkfz.de/record/304586